The key role of sphingosine kinases in the molecular mechanism of neuronal cell survival and death in an experimental model of Parkinson's disease

被引:55
作者
Pyszko, Joanna A. [1 ]
Strosznajder, Joanna B. [1 ]
机构
[1] Polish Acad Sci, Dept Cellular Signalling, Mossakowski Med Res Ctr, Warsaw, Poland
关键词
sphingosine kinases; dopaminergic neurons; apoptosis; PD model; NEUROBLASTOMA SH-SY5Y CELLS; ALPHA-SYNUCLEIN; SPHINGOSINE-1-PHOSPHATE RECEPTORS; SPHINGOLIPID METABOLISM; DOPAMINERGIC-NEURONS; GENE-EXPRESSION; LIPID RAFTS; 1-PHOSPHATE; CERAMIDE; APOPTOSIS;
D O I
10.5114/fn.2014.45567
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Sphingosine kinases (Sphk1/2 EC 2.7.1.91) are responsible for synthesis of sphingosine-1-phosphate (S1P) and for regulation of the bioactive sphingolipids homeostasis. Sphingosine-1-phosphate can act as a potent messenger in an autocrine/paracrine manner through five specific G protein-coupled receptors (GPCR) S1P1-5. This sphingolipid is involved in the mechanism of transcription, mitochondrial function, neuronal viability and degeneration. Until now the involvement of Sphk1/2 and sphingolipid alterations in Parkinson's disease (PD) remains unknown. Recent studies have indicated the role of sphingolipids in the regulation of alpha-synuclein (ASN) in the PD brain. Our latest data demonstrated significant inhibition of Sphk1 gene expression and activity in an in vitro PD model, induced by 1-methyl-4-phenylpyridinium (MPP+). The aim of this study was to investigate the role of Sphks inhibition in ASN secretion and in the molecular mechanism of neuronal death in the PD model. Our study was carried out using neuronal dopaminergic SH-SY5Y control cells, transfected with the human gene for ASN or with an empty vector These cells were treated with MPP+ (1-3 mM), which represents an experimental PD model, or with the Sphks inhibitor (1-5 mu M SKI II) for 3-24 h. Our data indicated that MPP+ (3 mM) induced significant alterations of Sphks and S1P lyase (SPL) gene expression. Reduced activity of Sphk1 and Sphk2 in the cytosolic fraction and in the crude nuclear fraction, respectively, was observed. Sphks inhibition evoked enhancement of ASN secretion, suppression of PI3K/Akt phosphorylation and activation of gene expression for the pro-apoptotic Bcl-2 proteins Bax and BH3-only protein Harakiri. Moreover, a lower level of cytochrome c in the mitochondrial fraction and caspase-dependent degradation of DNA-bound enzyme poly(ADP-ribose) polymerase (PARP-1) were observed. The caspase inhibitor (20 mu M Z-VAD-FMK) significantly enhanced neuronal cell viability in MPP+ oxidative stress. However, exogenous S1P (1 mu M) exerted a more efficient neuroprotective effect as compared to Z-VAD-FMK. In summary, these data indicated that Sphk1 inhibition plays an important role in caspase-dependent apoptotic neuronal death in an experimental PD model.
引用
收藏
页码:260 / 269
页数:10
相关论文
共 59 条
  • [1] Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease
    Abbott, Sarah K.
    Li, Hongyun
    Munoz, Sonia Sanz
    Knoch, Bianca
    Batterham, Marijka
    Murphy, Karen E.
    Halliday, Glenda M.
    Garner, Brett
    [J]. MOVEMENT DISORDERS, 2014, 29 (04) : 518 - 526
  • [2] Adamczyk A, 2007, FOLIA NEUROPATHOL, V45, P230
  • [3] Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells:: role of Bcl-2 expression
    Bektas, M
    Jolly, PS
    Müller, C
    Eberle, R
    Spiegel, S
    Geilen, CC
    [J]. ONCOGENE, 2005, 24 (01) : 178 - 187
  • [4] Regulation by sphingosine 1-phosphate of Bax and Bad activities during apoptosis in a MEK-dependent manner
    Betito, S
    Cuvillier, O
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 340 (04) : 1273 - 1277
  • [5] Brugg B, 1996, J NEUROCHEM, V66, P733
  • [6] Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer's disease
    Ceccom, Johnatan
    Loukh, Najat
    Lauwers-Cances, Valerie
    Touriol, Christian
    Nicaise, Yvan
    Gentil, Catherine
    Uro-Coste, Emmanuelle
    Pitson, Stuart
    Maurage, Claude Alain
    Duyckaerts, Charles
    Cuvillier, Olivier
    Delisle, Marie-Bernadette
    [J]. ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2014, 2
  • [7] Lipid Pathway Alterations in Parkinson's Disease Primary Visual Cortex
    Cheng, Danni
    Jenner, Andrew M.
    Shui, Guanghou
    Cheong, Wei Fun
    Mitchell, Todd W.
    Nealon, Jessica R.
    Kim, Woojin S.
    McCann, Heather
    Wenk, Markus R.
    Halliday, Glenda M.
    Garner, Brett
    [J]. PLOS ONE, 2011, 6 (02):
  • [8] Docosahexaenoic acid and tetracyclines as promising neuroprotective compounds with poly(ADP-ribose) polymerase inhibitory activities for oxidative/genotoxic stress treatment
    Cieslik, Magdalena
    Pyszko, Joanna
    Strosznajder, Joanna B.
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2013, 62 (05) : 626 - 636
  • [9] Disruption of Sphingosine 1-Phosphate Lyase Confers Resistance to Chemotherapy and Promotes Oncogenesis through Bcl-2/Bcl-xL Upregulation
    Colie, Sandra
    Van Veldhoven, Paul P.
    Kedjouar, Blandine
    Bedia, Carmen
    Albinet, Virginie
    Sorli, Sonia-Caroline
    Garcia, Virginie
    Djavaheri-Mergny, Mojgan
    Bauvy, Chantal
    Codogno, Patrice
    Levade, Thierry
    Andrieu-Abadie, Nathalie
    [J]. CANCER RESEARCH, 2009, 69 (24) : 9346 - 9353
  • [10] Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer's disease pathogenesis
    Couttas, Timothy A.
    Kain, Nupur
    Daniels, Benjamin
    Lim, Xin Ying
    Shepherd, Claire
    Kril, Jillian
    Pickford, Russell
    Li, Hongyun
    Garner, Brett
    Don, Anthony S.
    [J]. ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2014, 2